Tl. Phillips et Gy. Ross, EFFECTS OF CYTOTOXIC CHEMOTHERAPEUTIC-AGENTS ON SPLIT-DOSE REPAIR IN INTESTINAL CRYPT CELLS, International journal of radiation oncology, biology, physics, 39(4), 1997, pp. 817-822
Citations number
11
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: Many cancer chemotherapeutic agents interact with radiation t
o enhance the amount of radiation damage observed in both tumor and no
rmal tissues, It is important to predict this interaction and to deter
mine the effect of drug on sublethal damage repair, To evaluate for ef
fects in rapid renewing normal tissues, the intestinal crypt cell in v
ivo assay is an excellent one to employ, These studies investigate the
effect of eleven cancer chemotherapeutic drugs on split-dose repair i
n the intestinal crypt cell of the mouse. Methods and Materials: LAF1
male mice, age 10-12 weeks, were exposed to whole-body irradiation wit
h orthovoltage x-rays delivered as a single dose or as equally divided
doses delivered with intervals between the two exposures of 2 to 24 h
, In the experimental group, the cancer chemotherapeutic agent was adm
inistered intraperitoneally 2 h before the first radiation dose, At 3.
6 days after the second irradiation, the mice were sacrificed; the jej
unum was removed, fixed, and sectioned for light microscopy, The numbe
r of regenerating crypts were counted and corrected to represent the n
umber of surviving cells per circumference. Results: Of the eleven dru
gs tested, only carmustine eliminated split-dose repair, Cisplatin del
ayed repair, and methotrexate caused marked synchronization obliterati
ng the observation of split-dose repair. Conclusions: Most cytotoxic c
hemotherapeutic agents do not inhibit sublethal damage repair in intes
tinal crypt cells when given 2 h before the first radiation exposure,
Absence of the initial increase in survival seen with split-dose radia
tion is noted with carmustine and high-dose methotrexate. (C) 1997 Els
evier Science Inc.